Previous Close | 9.31 |
Open | 9.32 |
Bid | 9.04 x 300 |
Ask | 9.18 x 300 |
Day's Range | 8.95 - 9.44 |
52 Week Range | 4.89 - 22.69 |
Volume | |
Avg. Volume | 4,094,880 |
Market Cap | 525.211M |
Beta (5Y Monthly) | 2.13 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.08 |
Earnings Date | May 20, 2024 - May 24, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.50 |
PETACH TIKVA, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (“SEC”) on April 22, 2024. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at ht
In this article, we will take a detailed look at ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential. For a quick overview of such stocks, read our article ChatGPT Stock Predictions: 5 Stocks That Have 10X Potential. From taking customer service calls to composing music, AI has already started showing its prowess and impact all over the world. […]
With the business potentially at an important milestone, we thought we'd take a closer look at Nano-X Imaging Ltd.'s...